<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0378-4835</journal-id>
<journal-title><![CDATA[Oncología (Barcelona)]]></journal-title>
<abbrev-journal-title><![CDATA[Oncología (Barc.)]]></abbrev-journal-title>
<issn>0378-4835</issn>
<publisher>
<publisher-name><![CDATA[Alpe Editores, S.A.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0378-48352004000700002</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Prostate brachytherapy: brief history and the evolution of the different techniques]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Polo]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Marsiglia]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Instituto Catalán de Oncología  ]]></institution>
<addr-line><![CDATA[Barcelona ]]></addr-line>
<country>España</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Institute Gustave Roussy  ]]></institution>
<addr-line><![CDATA[Paris ]]></addr-line>
<country>Francia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>07</month>
<year>2004</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>07</month>
<year>2004</year>
</pub-date>
<volume>27</volume>
<numero>7</numero>
<fpage>13</fpage>
<lpage>13</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S0378-48352004000700002&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S0378-48352004000700002&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S0378-48352004000700002&amp;lng=en&amp;nrm=iso"></self-uri></article-meta>
</front><body><![CDATA[ <p align="right"><b><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2">C&Aacute;NCER    DE PR&Oacute;STATA</font></b></p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="4"><b>Prostate    brachytherapy: brief history and the evolution of the different techniques</b></font></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>A. Polo<sup>I</sup>;    H. Marsiglia<sup>II</sup></b></font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"> <sup>I</sup>Instituto    Catal&aacute;n de Oncolog&iacute;a. Barcelona. Espa&ntilde;a</font>    <br>   <font face="Verdana, Arial, Helvetica, sans-serif" size="2"><sup>II</sup>Institute    Gustave Roussy. Paris. Francia</font></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     ]]></body>
<body><![CDATA[<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Brachytherapy with    permanent radioactive seeds is the most conformal therapy for treating localized    prostate cancer. In the last 15 years there have been a renewed interest as    a treatment option due to technological improvements (new ultrasound machines,    better treatment planning systems, new isotopes) and the publication of encouraging    clinical series from the group of investigators in Seattle.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Alexander Graham    Bell was the first to describe the idea of putting radioactive sources in the    prostate. In a letter dating back to the 1890's he discussed placing radium    inside a glass bead and inserting it inside the prostate. However, Pasteau and    Degrais in Paris reported the first actual procedures in 1913. Several other    investigators followed this seminal report. This primitive technique consisted    in placing non-sealed sources of radioactive gold into the prostate by an open    perineal approach.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The field was significantly    advanced by the work of Hilaris and Whitemore, who in the early 1970's, developed    a technique for implanting the prostate with radioactive isotopes using permanent    sealed sources. Using a surgical approach, they exposed the prostate gland and    prepared it for seed implantation. The prostate volume was determined in the    operating room and the total activity of I-125 required for the implant was    obtained from a nomogram, specifically developed for this technique. Needles    were then inserted into the prostate through the exposed retropubic space, with    a free hand technique, using a finger in the rectum to guide their depth. This    technique was performed over a 15 year period with what appeared to be very    encouraging early results. However, it eventually became obvious that the local    failure rate was higher than what would have been anticipated. In those days    a failure was determined by an enlarging prostate nodule, an elevated acid phophatase    or a positive bone scan. PSA was not available and post-implant prostate biopsies    were not routinely done. Other problems with this technique included incorrect    prostate volume measurements, loss of sources in the urinary tract, and lack    of adequate dosimetric evaluation. Thus, the retropubic open implant was abandoned    by the mid 1980's.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The "modern" era    of prostate brachytherapy evolved from the work by Holm in Denmark who began    to use transrectal ultrasound to help plan seed placement. At that time, in    the early 1980's only crude axial imaging was available and very rudimentary    dosimetry systems were used to plan the implant and to determine the adequacy    of the procedure. Holm used a monoplanar transrectal ultrasound probe that could    only image the prostate gland in transverse or axial mode. The axial images    were used to construct a map for seed placement.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Ragde and Blasko    extended Holm's initial work and developed an ultrasound guided transperineal    technique incorporating a comprehensive planning method. Prostate images taken    in a previous procedure are digitalized thanks to sophisticated software packages.    These images were then reconstructed and a predictive dosimetry is generated    giving a seed deposition plan. In the operating room the physician follows the    plan by attempting to guide the needles with the seeds into the predetermined    coordinates. Seeds can be inserted by a number of techniques. The needles can    be loaded with loose seeds, before the implant (pre-loaded needles) or during    the implant (Mick applicator-based technique). An alternative to loose seeds    is using seeds woven in polyglycolic strands. The strands can be cut to accommodate    the number of seeds required per needle.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In the recent years,    progresses have been made allowing intraoperative optimization of treatment    plans via dynamic dose calculations of planned needles or deposited seeds. This    can open the therapeutic window improving biochemical control and reducing the    associated toxicity of seed implantation.</font></p>     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In the corresponding    session, a description of the history of permanent seed implantation in Spain    will be made and a survey of the different techniques will be presented.</font></p>      ]]></body>
</article>
